Abstract: Atopic dermatitis is a chronic inflammatory skin disease with a complex pathogenesis, where changes in skin barrier and imbalance of the immune system are relevant factors. The skin forms a mechanic and immune barrier, regulating water loss from the internal to the external environment, and protecting the individual from external aggressions, such as microorganisms, ultraviolet radiation and physical trauma. Main components of the skin barrier are located in the outer layers of the epidermis (such as filaggrin), the proteins that form the tight junction (TJ) and components of the innate immune system. Recent data involving skin barrier reveal new information regarding its structure and its role in the mechanic-immunological defense; atopic dermatitis (AD) is an example of a disease related to dysfunctions associated with this complex.
INTRODUCTION
Atopic dermatitis (AD) is a highly prevalent dermatosis in the population, especially in children. It has a chronic, inflammatory and pruriginous nature and progresses with periods of exacerbation. Its increasing prevalence in recent decad ranges from 10% to 20% in children and reaches 3% in adults. 1, 2 AD can be associated with other manifestations of atopic disease such as asthma and rhinitis, which occur more frequently in patients with recalcitrant AD. 1 For many years, the altered immune response in AD has been considered the main mechanism for inflammation and changes in skin permeability (inside-ouside theory). However, the outside-inside theory was then conceived, and the skin barrier defects in AD proved to exert a key role in the pathogenesis of AD. 3, 4 This review aims to focus on dysfunction of proteins of the skin barrier (filaggrin and claudins 1 and 4) and of components of the innate immune system (pattern recognition receptors, secretory elements, predominant cells of the innate immune system and skin microbiota) in AD patients, which contribute to the constant AD phenotype of xerosis, inflammation and susceptibility to infections.
SKIN BARRIER
Protection and defense are the main functions of the skin.
Regulation of the transepidermal water loss (TEWL), defense against the action of external physico-chemical agents and aggression of microorganisms are part of the skin barrier. The stratum corneum (SC) is the main component of such barrier, and is based on the "brick and mortar" structure. Its filmogenic feature is due to the association of SC with surface lipids. 5 Filaggrin and proteins of the tight junctions (TJs) have been the most studied components of the skin barrier. Filaggrin, after hydrolyzed, contributes to the formation of relevant components for pH maintenance, moisture and skin protection against microbial agents. TJ protein with active expression, on the other hand, are important to control the selective permeability of the epidermis to build the barrier against the external environment, therefore promoting recognition of the cell "territory". 6 
Skin barrier proteins with functional relevance

Filaggrin
Filaggrin is a protein originated from pro-filaggrin, produced by keratinocytes. It is the main component of keratohyalin granules, visualized by light microscopy within the granular layer.
Conversion of pro-filaggrin into filaggrin, both intracellular proteins, occurs through dephosphorylation and proteolysis by serine proteases, releasing multiple active monomers of filaggrin. 7 With the decrease of the water gradient in the outer layers of the epidermis, filaggrin hydrolysis occurs in hygroscopic amino acids. 8, 9 Factors such as age, ultraviolet B radiation, relative humidity and hypoxia affect this process. 10, 11 Hygroscopic amino acids, especially arginine, glutamine and histidine are detected within the intercellular space. 10 They generate the natural moisturizing factors (NMF), responsible for the maintenance of SC and pH hydration for the production of urocanic acid (UCA) in its cis and trans forms, as well as 5-pyrrolidone carboxylic acid (PCA). 10, 12, 13 Furthermore, these two byproducts filaggrin have inhibitory effects on the Staphylococcus aureus (S. aureus) growth.
14 Changes in barrier proteins, such as decreased expression of filaggrin in the skin, and mutations with loss of function in filaggrin gene (FLG), such as those found in ichthyosis vulgaris, have been described in AD. 10, 15 These mutations lead to increased risk of early onset of the disease, respiratory atopy, allergies, elevated IgE serum levels and persistence of AD in adulthood. 16 Moreover, there is a significant relationship between AD with FLG mutation and peanut allergy mediated by IgE, indicating an increased skin permeability and consequent enhanced exposure to allergens.
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Interleukins (IL) 4 and 13, detected in AD lesions, also lead to decreased expression of filaggrin in keratinocytes. 18 The family of IL-1 has relevant pro-inflammatory features, such as IL-1α, suggesting that the onset of inflammation may occur due to changes in the skin barrier. Morevoer, there are reports of decrease of NMF in the SC of individuals with AD and mutations in the FLG gene, with increase of IL-1 family cytokines in non-inflammed skin. 19 Therefore, patients with AD and deficiency in FLG expression have decreased SC hydration, increased TEWL, and higher pH than non-atopic individuals, with an augmented risk of developing allergies, asthma and rhinitis. 20 Changes in the skin barrier due to filaggrin deficiency may also lead to inflammation, and reduced protein expression in keratinocytes (Chart 1).
Tight junctions
TJ are formed by a complex of transmembrane and intracellular proteins found in simple and stratified mammalian epithelia. In normal skin, they are detected in the granular layer, and its expression rapidly increases after injury. They are essential for cell differentiation and keratinization of epidermal cells. 6 In skin diseases with altered keratinization, such as psoriasis and ichthyosis vulgaris, they are present even in the deeper layers of the epidermis. 21 TJ play an important role in epidermal selective permeability, controlling intercellular flow of substances such as hormones, cytokines and electrolytes, functioning as "gates". This permeability depends directly on the size and ionic specificity of the molecule. In addition to the intercellular permeability function, these structures also act as markers of the cell "territory". 22 The intracellular portion of TJ binds to cytoskeletal plasma proteins, while the extracellular portion forms a "loop" in the intercellular space, connecting with the adjacent cell loop. TJ are formed by occludin, claudin, zonula occludens 1 (ZO1) and 2 (ZO2), junctional adhesion molecule-1 (JAM1) and the multi-PDZ-1 protein (MUPP1). 23 In 2002, Tsukita and Furuse showed that claudin 1 deficiency in mice led to high TEWL and liver abnormalities, culminating with death. 22 These animals showed no structural abnormalitie, but significant loss of function of the skin barrier. A similar clinical condition of claudin 1 deficiency was described in human neonates (ichthyosis-sclerosis-cholangitis syndrome).
24
TJ proteins also play an important role in the invasion of some viruses (e.g.: herpes simplex) and bacteria. Some of these organisms use claudin 1 as receptors; others modulate the structure of TJ, inserting effectors, activating signals or even directly connecting to them, resulting in their partial break. 25, 26 Its expression rapidly increases via activation of toll-like receptor 2 (TLR2).
27
The lesional skin of atopic patients contains significant decreased claudin 1 expression, but no claudin 4 reduction, when compared to the skin of non-atopic individuals ( Figure 1 ). [28] [29] [30] Reduced claudin 1 appears to be related to increased risk of infection by herpes virus type 1 (HSV1) in individuals with AD. 25 There is also an inverse relation between the expression of claudin 1 and the presence of the immune response markers Th2, suggesting that this protein affects the immune response to potential environmental allergens (Chart 2). 
TLR family
TLRs are well-known transmembrane proteins that play as innate receptors. In humans, TLR1-10 have been described and they have the ability to recognize pathogen-associated molecular patterns (PAMPs). TLR1, 2, 4-6,10 are in charge of such recognition on the cell surface, whereas TLR3, 7-9 are found in the endosomes. 33 They also recognize endogenous ligands in response to tissue damage, contributing to the maintenance of skin barrier. 34, 35 There are four main subclasses of inflammasomes: NRLP3, NLRP1, IPAF (also known as NLRC4-NLR Family, CARD Domain Containing 4) and AIM2 (absent in melanoma 2). 37 Changes in expression of NLRP1 gene were associated to AD severity. 42 Impaired NLRP3 expression may partially explain how skin colonization and infection with S. aureus can contribute to chronic skin inflammation in AD. 43 Increased epidermal expression of IL-1β cytokine has been observed in AD patients presenting FLG mutations. 19 It was demonstrated enhanced levels of IL-18 both in sera and culture supernatants under staphylococcal enterotoxin A stimuli in AD patients. 
Antimicrobial peptides (AMP)
AMPs play an important role in the skin innate immunity acting as endogenous antibiotics. Cathelicidin (LL37) and β-defensin family are the main AMPs, but other keratinocyte products are also recognized for their anti-microbial functions, such as ribonuclease (RNase), S100 family, dermcidin and regenerating islet-derived (REG3α). There is a wide group of microorganisms that colonize the skin; rather than passive inhabitants, they actively interact with host cells and influence the innate immune response. 63 There is poor bacterial diversity in active lesions of AD, with predominance of S.
aureus; once the patient reaches control, the bacterial milieu is then at least partially recovered. Interestingly, the number of commensal bacteria (Staphylococcus epidermidis) increases during exacerbations of AD, suggesting a compensatory mechanism to control S. aureus. 64 S. epidermidis produces two AMP (phenol-soluble modulins γ and δ), which are selective for skin pathogens, such as S. aureus, group A Streptococcus, and Escherichia coli, but do not combat S. epidermidis. 65 Furthermore, LTA released by S. epidermidis inhibits skin inflammation during tissue damage, through a TLR2-dependent mechanism. 66 Finally, small molecules secreted by S. epidermidis increase the expression of human β-defensin by human keratinocytes through TLR2 signaling pathway. These findings evidence a potential inhibition of the skin microflora on survival of cutaneous pathogens, while promoting recovery of the normal skin microbiota. 32 The skin microbiota in patients with AD is altered by en- 
